Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model
Authors:
- 10 July 2011
- journal article
- Published by Springer Nature in Angiogenesis
- Vol. 14 (3) , 393-405
Abstract
In this study, we introduce a technique for repeated, microscopic observation of single regressing capillaries in vivo in inflamed murine corneas. Natural capillary regression was initiated by removal of inflammatory stimulus during an active pro-angiogenic phase, while the additional impact of anti-angiogenic treatment with triamcinolone or bevazicumab was investigated. Capillaries regressed naturally within 1 week and treatments did not further enhance the natural regression. Morphologically, early-phase regression was characterized by significant lumen narrowing and a significant reduction in CD11b+ myeloid cell infiltration of the extracellular matrix. By 1 week, vascular remodeling occurred concomitant with CD11b+CD68+KiM2R+ mature macrophage localization on capillary walls. Empty conduits without blood flow, positive for collagen IV and devoid of vascular endothelium and pericytes, were apparent in vivo and by 3 weeks were more numerous than perfused capillaries. By 3 weeks, macrophages aggregated around remaining perfused capillaries and were observed in apposition with degrading capillary segments. Abrupt termination of capillary sprouting in our regression model further revealed vascular endothelial abandonment of sprout tips and perfused capillary loop formation within a single angiogenic sprout, possibly as an intussusceptive response to cessation of the stimulus. Finally, we observed lumen constriction and macrophage localization on capillary walls in vivo in a clinical case of corneal capillary regression that paralleled findings in our murine model.Keywords
This publication has 38 references indexed in Scilit:
- Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant SurvivalInvestigative Ophthalmology & Visual Science, 2010
- Effect of Subconjunctival and Intraocular Bevacizumab Injections on Corneal Neovascularization in a Mouse ModelCurrent Eye Research, 2010
- Topical Bevacizumab in the Treatment of Corneal NeovascularizationArchives of Ophthalmology (1950), 2009
- Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodelingAngiogenesis, 2009
- Tumor Recovery by Angiogenic Switch from Sprouting to Intussusceptive Angiogenesis after Treatment with PTK787/ZK222584 or Ionizing RadiationThe American Journal of Pathology, 2008
- MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic RetinopathyInvestigative Ophthalmology & Visual Science, 2008
- Tumour vascularization: sprouting angiogenesis and beyondCancer and Metastasis Reviews, 2007
- Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cellsNature Biotechnology, 2007
- G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanismBlood, 2006
- Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular NeovascularizationThe American Journal of Pathology, 2006